SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Operating margin 2024–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) operating margin by fiscal year — reported operating income divided by reported revenue.
-575.3%FY2025 · since FY2024: -1312.8% → -575.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -575.3% | +737.5 pp |
| FY2024 | -1312.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →